(Q67760102)
Statements
Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification (English)
Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: Initial weekly treatment followed by rescheduling and intensification (English)
C. J. Twelves
M. A. Richards
P. Smith
1 October 1991